As these therapies evolve, primary care will be at the forefront of integrating them into holistic, patient-centered management, says Kyle Lee, BMLSc, BMBS, MPH, CCFP, Sermo medical advisory board member, in a release
and levothyroxine, requiring separation by 4 hours) [9] [10] Any decision to combine these medications should be made collaboratively between patient and prescriber, with careful consideration of individual circumstances, treatment goals, previous responses to monotherapy, and the patient's ability to tolerate potential side effects
Disruptions in this cycleoften driven by inflammation or impaired blood flowcan lead to hair thinning and loss
Patients with underlying endocrine disorders such as hypothyroidism should have these conditions optimally treated before assessing response to weight loss medication